Precigen, Inc. (PGEN) Advances Gene Therapy InnovationPrecigen, Inc.BATS:PGENtraderspro_chartsPrecigen, Inc. (PGEN) is a biotechnology company pioneering gene and cell therapies for cancer, autoimmune, and rare diseases. Its proprietary UltraCAR-T® and ActoBiotics® platforms are designed to create targeted, efficient, and scalable treatments. Precigen’s growth is fueled by promising clinical trial results, strategic partnerships, and the expanding potential of next-generation genetic therapies to transform patient outcomes across multiple disease areas. On the chart, a confirmation bar with rising volume highlights bullish sentiment. The price has entered the momentum zone after breaking above the .236 Fibonacci level. A trailing stop can be placed just below this Fibonacci line using the Fibonacci snap tool, helping traders protect gains while leaving room for continued upside potential.